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The aim of this study was the characterization of the in vitro cytotoxic properties of a 
recently isolated diterpene compound, 7β-acetoxy-20-hydroxy-19,20-epoxyroyleanone 
(compound 1), extracted from Salvia corrugata, versus human cell lines.  
Main Methods 
We used as model study immortalized breast epithelial cells MCF10A and two ERBB2+ 
breast cancer (BCa) cell lines, SKBR-3 and BT474. Compound 1 was isolated by 
methanolic extraction from regenerated shoots of Salvia corrugata Vahl, and purified 
by high pressure liquid chromatography (HPLC). Flow cytometry (FCM) was employed 
for cell cycle, apoptosis and reactive oxygen species (ROS) analysis. Cell morphology 
was assessed by immunofluorescence and transmission electron microscopy (TEM). 
Key Findings 
Compound 1 inhibited cell survival of all breast cell lines. In particular, compound 1 
promoted cell cycle arrest in the G0/G1 phase and apoptosis along with impairment of 
the mitochondrial function, which was reflected in a gross alteration of the 
mitochondrial network structure. Furthermore, we also detected a potent activation of 
the ERK1/2 kinase, which suggested the induction of reactive oxygen species (ROS). 
Partial rescue of survival obtained with n-acetylcysteine (NAC) when coadminstered 
with compound 1 further supported a contribution of ROS mediated mechanisms to the 
growth-arrest and proapoptotic activity of compound 1 in both BCa cell lines. ROS 

















Our findings show that compound 1 has a cytotoxic activity against both human normal 
and cancer cell lines derived from breast epithelia, which is mediated by ROS 
generation and mitochondrial damage. 
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Breast cancer (BCa) is one of the most common malignancies in women and the 
associated mortality is primarily due to the development of metastatic disease [1]. 
Progression of the disease involves the acquisition of adaptive changes within tumor 
cells and the tumor microenvironment. Nowadays, gene expression profiling has 
identified four main subtypes of breast cancer that differ in driver genes and optimal 
therapies [2, 3]. The human epidermal growth factor receptor-2 (ERBB2)-positive 
(ERBB2+) subtype, characterized by overexpression of ERBB2 receptor, represents up to 
20% of cases and has high rates of metastases. Novel findings on the ERBB2+ subtype 
have revealed that it has a distinctive transcriptional landscape that reflects androgen 
receptor signaling as replacement for estrogen receptor (ER)-driven tumorigenesis [4]. 
In addition to development of novel targeted drugs, the search for safer and effective 
chemoprevention for aggressive breast cancers would effectively help the management 
















natural phytochemical compounds is an emerging strategy that aims to prevent and/or 
delay cancer progression.  
A series of diterpenes and triterpenes, mainly obtained from genera of the Lamiaceae 
family have shown antineoplastic effects coupled with low toxicity profiles [6]. Recently, 
the effects of carnosic acid (CA), a diterpene obtained from various genera of 
Lamiaceae like Salvia officinalis L. and Rosmarinus officinalis L., have been investigated 
in human glioblastoma and breast cancer cells [7, 8]. This latter study reported, in 
particular, the potential benefit of the use of CA in the treatment of ERBB2+ and 
Trastuzumab resistant BCa cell lines. However, many studies performed with the 
diterpenes did not evaluate the effects of these compounds on normal human cells, 
which is essential to determine a potential use in cancer therapy. 
The 7β-acetoxy-20-hydroxy-19,20-epoxyroyleanone (7β-acetoxy-12,20-dihydroxy-
19,20-epoxy-11,14-dioxoabieta-8,12-diene) (compound 1) is a diterpenoid extracted 
from regenerated shoots of Salvia corrugata Vahl, which structural formula is shown in 
Fig. 1. This compound showed weak antimicrobial activity against methicillin-resistant 
Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE) 
and vancomycin resistant nterococcus faecium (VRE) [9]. The aim of this study was to 
characterize at the molecular level the cytotoxic effects of compound 1 on human 
ERBB2+ breast cancer and normal breast epithelial cell lines to determine its potential 
use in cancer therapy.  
 
2. Materials and Methods 
 
















The methanolic extracts of regenerated shoots of Salvia corrugata Vahl (1.48 g) (b) 
were fractionated by Si gel MPLC (Merck Kiesegel 60, 230-400 mesh, 200 g) (Merck, 
Darmstadt, Germany) eluting with n-hexane/CHCl3/CH3OH at concentrations varying 
from 100:0:0 to 0:0:100 (a: 3.0 L; b: 1.5 L) to obtain 16 fractions (1-16). [9] 
Fraction 9b (146.3 mg) (eluted with CHCl3, from 0.55 to 0.63 L) was purified by semi-
preparative RP HPLC (Symmetry 300 C18 column, 7.8x300 mm ID, 7 m particle size 
(Waters), flow rate of 2.0 mL/min, elution mixture composed of water (A) and CH3OH 
(B), gradient elution of A:B from 95:5 to 0:100 over 61 min) and afforded 1 (4.3 mg 
HPLC purity ≥ 98%). 
 
2.2 Cell Cultures 
The BC cell lines SKBR-3 and BT474 were obtained from Banca Biologica and Cell 
Factory in IRCCS Ospedale Policlinico San Martino belonging to the European Culture 
Collection’s Organization. Cells were cultured in DMEM high glucose supplemented 
with 10% heat-inactivated fetal bovine serum, 1% glutamine, penicillin and 
streptomycin purchased from Euroclone S.p.A. Control SKBR-3 and BT474 cultures were 
challenged with DMSO (a suitable solvent for compound 1) at a final concentration of 
0.05% and 0.075%, respectively. MCF10A cells were obtained from NIH Institute and 
cultured according to the manufacturer’s instructions. 
 
2.3 Cell survival assay 
Cells were plated in 24-well plates in complete medium (triplicate of SKBR-3 28000 
















survival was measured using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium 
bromide (MTT) colorimetric assay. 
 
2.4 Flow cytometry (FCM) analysis 
Both adherent and floating cells were collected after 48h of treatment and centrifuged 
at 980 g for 5 min. DNA content in cell nuclei was measured by staining with DAPI and 
high resolution DNA flow cytometry (hr DNA-FCM) using a Sysmex-Partec  CyFlow ML 
flow cytometer. Cell cycle phases were determined by using the Partec CyFlow 
software.  
Apoptotic and necrotic cells were evaluated by using the Vybrant Apoptosis Assay Kit 
purchased from Thermo Fisher Scientific with a minor procedure modification as we 
used the nuclear staining fluorochrome sytox blue instead of the sytox green. Cells 
were then analyzed using using a Beckman Coulter Cyan ADP flow cytometer.  
To evaluate ROS generation, we used the the cell-permeant ROS probe 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) (also known as dichlorofluorescin 
diacetate) from Thermo Fisher. After 48h incubation of the cells with compound 1, we 
rapidly washed the cells with HBSS and next incubated in HBSS in the presence of 1µM 
H2DCFDA for 45 min. Cells were then washed and resuspended in HBSS and 
immediately analyzed using the Cyan ADP flow cytometer. 
To measure mitochondrial membrane potential, we used the fluorescent lipophilic 
cation dye JC1 purchased from Thermo Fisher Scientific. Briefly, cells were incubated 
with 3 µM JC1 for 30 min at 37°C in a humidified incubator with 5% CO2 atmosphere, 

















2.5 Immunoblot analysis 
SKBR-3 cells were lysed using lysis buffer (Hepes pH 7.4 20 mM, NaCl 150 mM, 10% 
Glycerol, 1% Triton X-100) containing a protease inhibitors cocktail (Complete) and a 
phosphatases inhibitor (Phostop) both purchased from Roche Applied Science. Proteins 
were resolved on SDS-polyacrylamide gel electrophoresis and blotted on a PVDF 
membrane. Detection was performed with ECL Detection Reagent purchased from 
BioRad according to manufacturer’s protocol. ECL signals were detected and recorded 
by the Li-Cor scanner and the Nine Aliance, Uvitec Cambridge, gel documentation 
apparatus. Antibodies against Poly(ADP-Ribose) Polymerase (PARP) and anti-ERK1/2 
were purchased from Cell Signaling Technologies Inc. while the anti-tubulin antibody 
was purchased from Sigma Aldrich. The antibody specific for the ERBB2 N-terminal 
domain was purchased from Thermo (Ab-20), the anti-phospho-ERK1/2 (Thr 202/Tyr 
204) was purchased from Santa Cruz Biotechnology. 
 
2.6 Mitochondrial morphology analysis 
To perform epifluorescence analysis, cells were grown on cover slip and mitochondria 
were stained with 23.5 µM MitoTracker Red CMXRos while nuclei were stained with 5.9 
µM Hoechst 33342, both purchased from Thermo Fisher Scientific, for 20 min at 37°C in 
a humidified incubator with 5% CO2 atmosphere. Cells were washed with fresh medium 
and incubated in medium for further 20 min at 37°C in incubator. Fixation was 
performed with PFA 3.7%, 2% sucrose in PBS for 5 min at room temperature. Cells were 
washed with PBS and mounted on a glass slide. Epifluorescence and real time 
deconvolution and acquisition was performed with an Zeiss Axio Imager A2M 

















2.7 TEM analysis 
For electron microscopy, SKBR-3 cells were seeded on glass chamber slides and treated 
with compound 1 for 48 h in parallel with control cells. After treatment, cells were 
washed out in 0.1 M cacodylate buffer and immediately fixed in 0.1 M cacodylate buffer 
containing 2.5% glutaraldehyde purchased from Electron Microscopy Science, for 1 h at 
room temperature. The cells were postfixed in osmium tetroxide for 2 h and 1% uranyl 
acetate for 1 h. Subsequently, samples were dehydrated through a graded ethanol 
series and flat embedded in resin Poly-Bed, purchased from Polysciences, for 24 h at 60 
°C [10]. Ultrathin sections (50 nm) were cut parallel to the substrate, stained with 5% 
uranyl acetate in 50% ethanol and observed with a Philips CM10 transmission electron 
microscope. Digital images were taken with a Megaview 2 CCD camera. 
 
2.8 ATP Synthesis Assay 
ATP synthesis rate was measured by the luciferin/luciferase chemiluminescent method. 
 
2.9 pERK/ERK ratio measurement 
Quantification of the pERK/ERK ratio was performed using the Alpha SureFire Ultra 
Multiplex ERK assay and the EnVision Multilabel Reader both purchased from Perkin-
Elmer.  
 
2.10 Statistical Analyses 
Statistical analyses were performed using the software Prism (GraphPad Software, La 
















All measurements here reported are presented as mean ± standard deviations (SD). For 
cell survival, apoptosis, mitochondrial membrane potential measure, ATP production, 
Alphaplex, and ROS production analysis we used a two-tailed distribution Student’s t-
test. For cell cycle phase analysis and cell survival in the presence and absence of NAC, 
we used one-way ANOVA plus post-hoc Newman-Keuls multiple comparison test. Mean 
differences were considered statistically significant (P value) at P<0.05.  
 
3. Results  
3.1 Compound 1 inhibits survival of breast epithelial cells  
To investigate whether compound 1 inhibited cell survival as reported for another 
diterpene with icetexane skeleton  Salvia corrugata [11, 12], we incubated two ERBB2+ 
BCa cell lines, SKBR-3 and BT474, with this substance for 48h, then performed an MTT 
assay. Indeed, we found that compound 1 inhibited in a concentration-dependent 
manner the survival of these cells (Fig. 2A). In particular, the compound 1 concentration 
that showed 50% inhibition of survival after 48 h of treatment compared to controls 
(IC50) were 50 µM and 75 µM for SKBR-3 and BT474, respectively (Fig. 2B). These IC50 
concentrations and a treatment of 48 h were used for all subsequent experiments with 
SKBR-3 and BT474. Control SKBR-3 and BT474 cultures were challenged with DMSO (a 
suitable solvent for compound 1) at a final concentration of 0.05% and 0.075%, 
respectively. 
To assess whether compound 1 was active against normal breast epithelial cells, we 
choose to use the MCF10A cell line that, although immortalized, are considered an 
acceptable model for normal human breast epithelial cells. We treated these cells for 
















performed an MTT assay. Control MFC10A cultures were treated with DMSO at a final 
concentration of 0.05%. Fig 2B shows that compound 1 indeed dramatically inhibited 
MCF10A survival. 
 
3.2 Compound 1 causes a cell cycle arrest in G0/G1 and apoptosis of ERBB2+ BCa cells  
To investigate whether a cell cycle progression arrest contributed to the observed 
inhibition of cell survival, we evaluated the DNA content of cell nuclei by hr DNA-FCM. 
This analysis showed that compound 1 increased the percentage of cells in the G0/G1 
phases compared to control cultures. This arrest in G0/G1 was accompanied by a 
reduction of the percentage of cells in the S phase in both SKBR-3 and BT474 (Fig. 3A-C). 
To establish whether the anti-proliferative effect of compound 1 was accompanied by 
apoptosis in ERBB2+ BCa cells, we performed an apoptosis assay. This assay allowed us 
to identify early apoptotic, late apoptotic, and necrotic cells. Representative FCM plots 
used to perform apoptosis analysis are provided in Fig. 4A. In particular, we found a 
higher number of early apoptotic cells in cultures of both cell lines treated with 
compound 1  compared to control cultures (P<0.05) (Fig. 4B). No statistically 
significantly differences were observed in the number of late apoptotic or necrotic cells 
between treated and control cultures (data not shown). Furthermore, immunoblot 
analysis of cell lysates showed cleavage of the Poly(ADP-Ribose) Polymerase (PARP) in 
cells treated with compound 1 but not in controls (Fig. 4C), which confirmed apoptosis 
induced by compound 1. 
 
















As ERBB2 and its downstream signaling which includes ERK1/2 modulation are key 
elements for ERBB2 BCa cells survival, we investigated whether compound 1 affected 
ERBB2 and pERK1/2 levels by immunoblot analysis. This analysis showed a minor 
reduction of ERBB2 levels in SKBR-3 and a major one in BT474 cells (Fig. 5A). In contrast, 
we observed a dramatic increase in ERK1/2 phosphorylation in both cell types (Fig. 5A). 
To better evaluate this increase we employed an assay able to detect simultaneously in 
cell lysates both total and phosphorylated ERK1/2 protein levels. The results showed 
that the ratio of the phosphorylated vs. total ERK1/2 levels were about 7-fold higher in 
both SKBR-3 (Fig. 5B) and BT474 (Fig. 5C) compound 1-treated cultures compared with 
controls (P<0.001). This indicated that compound 1 promoted activation of ERK1/2.  
 
3.4 Compound 1 causes ROS stress 
Because reactive oxygen species have been found to promote ERK activation [13], we 
decided to test whether compound 1 treated ERBB2 cells displayed generation of ROS. 
We labelled SKBR3 cells with the ROS probe H2DCFDA in the presence and absence of 
compound 1 and measured by FCM the median fluorescent intensity (MFI). A 
representative plot of this FCM analysis is shown in Fig. 6A.  The results showed a 
statistically significant (p<0.001) higher MFI in compound 1 treated cells compared to 
control cells (Fig. 6B). 
To demonstrate that compound 1 is responsible of the cell survival inhibition via ROS 
generation, we treated both cell lines with compound 1 in the presence of n-
acetylcysteine (NAC), a well-known anti-oxidant agent. We found in both SKBR-3 and 
BT474 a statistically significant (P<0.01) increase in survival between cells treated with 
















strongly suggested that a ROS mediated mechanism contributes to the proapoptotic 
and anti-survival activities of compound 1 in ERBB2+ BCa cell lines.  
 
3.5 Compound 1 causes mitochondrial damage 
It has been reported that activation of ERK1/2 can induce cell death under oxidative 
stress leading to mitochondria damage (Yagoda et al., 2007) For example, Ras-Raf-MEK-
dependent oxidative cell death is associated with the activation of mitochondrial 
voltage-dependent anion channels (VDACs) in non-neuronal cells [14], suggesting that 
mitochondrial membrane potential alterations may play an important role in MAPK-
dependent cell death.  Signs of mitochondrial dysfunction, which include mitochondrial 
fragmentation, decreased mitochondrial membrane potential (MMP), diminished ATP 
production and increased generation of reactive oxygen species (ROS) has been related 
to apoptosis [15]. Furthermore, we previously observed  that the diterpenoid demethyl 
fruticulin A (SCO-1), extracted from Salvia corrugata [16], impairs mitochondrial 
function [11]. Therefore, we sought to establish whether compound 1 has inhibitory 
effects on this organelle as well. First, we evaluated the mitochondrial membrane 
potential (MMP) in SKBR-3 by using a FCM based assay and the cationic fluorochrome 
JC1. Our analysis showed that compound 1 significantly reduced the mitochondrial 
membrane potential compared to controls (Fig. 7A, B). Second, we performed an ATP 
production assay in SKBR-3 cells to establish whether the reduction in the MMP 
translated in an impairment of ATP synthesis. As expected, our results showed that 

















To characterize the effects of compound 1 on mitochondria morphology, we performed 
an epifluorescence microscopy analysis with the MitoTracker Red CMXRos 
fluorochrome in SKBR-3 cells. In control cells, we promptly detected an extended 
mitochondrial network (Fig. 8A) whereas in compound 1-treated cells the mitochondrial 
network was collapsed (Fig. 8B). In particular, the MitoTracker Red CMXRos stained a 
compact perinuclear region where individual mitochondrial filaments were difficult to 
identify. Furthermore, cells displaying several donut-shaped mitochondria were 
frequently observed in compound 1-treated cultures (Fig. 8B), while they were only an 
occasional finding in control cells (not shown). Aberrant morphology of mitochondrial 
network would reflect alterations of their internal ultrastructure. We performed TEM 
analysis on SKBR3 cells and we observed distinct types of mitochondrial abnormalities 
upon treatment with compound 1 (Fig. 8C-F). In particular, we noted alterations and 
remodeling of inner cristae membranes, which are a common finding during stress 
and/or apoptosis. Compound 1–treated mitochondria mostly exhibit reduced and 
swollen cristae (Fig. 8D), which resemble the donut-shaped mitochondria observed by 
epifluorescence (Fig. 8B). In addition, several mitochondria show a completely 
disorganized inner membrane topology and occasionally, some mitochondria show 
small round inclusions in the mitochondrial matrix (Fig. 8E, F) and discontinuity of the 
outer membrane (Fig. 8F).  
 
4. Discussion 
The ERBB2 gene is amplified or overexpressed in approximately 30% of human breast 
cancers and in many other cancer types [10, 17-19]. The advent of ERBB2-directed 
















stage breast cancers. Nowadays, cancer chemoprevention and treatment using natural 
phytochemicals is emerging as an attractive and safer strategy in addition to 
conventional therapies. Because of the innate or acquired resistance of ERBB2+ breast 
cancers to currently available targeted agents, we performed the present in vitro study 
to assess the therapeutic potential of compound 1 by evaluating its effects on ERBB2+ 
cell growth and survival as well as ERBB2 downstream signaling. 
We have shown that compound 1 exerted a concentration-dependent growth inhibition 
in SKBR3 and BT474 ERBB2+ cell lines. In particular, we found that 1 induced a block of 
the cell cycle in the G0/G1 phase along with a reduction of the percentage of cells in the 
S and G2/M phases. Furthermore, compound 1 induced apoptosis as shown by a higher 
fraction of early apoptotic cells and PARP cleavage found in 1-treated cultures 
compared to controls. Overall, these results indicate striking anti-proliferative and 
proapoptotic activities for 1. Unfortunately, we found that 1 was also effective in 
inhibiting the growth of the MCF10A non transformed human mammary cells, thus 
limiting its potential therapeutic use. However, although this cell line is widely used as 
normal counterpart of breast cancer cell lines it should be considered that it is an 
immortalized line. Therefore, the effects of compound 1 on normal cells should be 
further investigated in future studies. Furthermore, as to our knowledge this is the first 
study on this compound, we cannot rule out that it may induce cell death at lower 
concentrations in other cancer cell types.  
Concerning the ERBB2 signaling, we investigated whether compound 1 affected ERBB2 
protein levels and both ERK1/2 activation and protein levels as downstream effector. 
We found that compound 1 effect on ERBB2 may be cell context dependent as it 
















SKBR-3 cells. On the contrary, compound 1 strikingly enhanced ERK1/2 activation in 
both cell types, while ERK1/2 protein levels were unaffected. A number of studies show 
that ERK1/2 has a pro-apoptotic role depending from the stimulus, cell type and 
downstream effectors activated [20]. As corroborating findings, apoptosis via ERK1/2 
activation has been demonstrated for triterpenes such as asiatic acid [21] and euphol 
[22]. Therefore, we suggest that compound 1 engages the apoptotic program via 
activation of ERK1/2 kinase. 
It has been reported that activation of ERK1/2 can induce cell death under oxidative 
stress leading to mitochondria damage. For example, Ras-Raf-MEK-dependent oxidative 
cell death is associated with the activation of mitochondrial voltage-dependent anion 
channels (VDACs) in non-neuronal cells [14], suggesting that mitochondrial membrane 
potential alterations may play an important role in MAPK-dependent cell death.  Signs 
of mitochondrial dysfunction, which include mitochondrial fragmentation, decreased 
mitochondrial membrane potential (MMP), diminished ATP production and increased 
generation of reactive oxygen species (ROS) has been related to apoptosis [15]. 
Consistently, we found that compound 1 strongly inhibited MMP and ATP production in 
both BC cell lines. As expected, dramatic changes in the mitochondrial network 
morphology were occurring upon 1 administration to BCa cells, as demonstrated by 
epifluorescence. Mitochondria often appeared collapsed and donut-shaped upon 
compound 1 treatment. At the ultrastructural level, we observed disarrangement and 
distortion of inner cristae membranes, which resembled the donut-shaped 
mitochondria observed by epifluorescence, and that are common during stress and/or 
apoptosis. Some mitochondria showed small round inclusions in the mitochondrial 
















mediated ERK1/2 activation in ERBB2+ BC cells is associated with MAPK-dependent cell 
death through ROS production and mitochondrial collapse, which eventually lead to 
apoptosis. In support to this hypothesis, we showed that the anti-oxidant NAC rescued 
cell survival of cells treated with compound 1. Therefore, we propose a model in which 
compound 1-mediated ROS production and ERK1/2 activation is associated with MAPK-
dependent cell death through mitochondrial collapse. 
In conclusion, we have shown that compound 1 exerts its anti-proliferative and killing 
effects by blocking the cell cycle in G0/G1 phase and by apoptosis activation, through 
ROS generation, mitochondrial dysfunction and collapse. However, this compound fails 
to exhibit clinical potential in ERBB2+ cancer due to requirement of rather high-doses to 
inhibit cell survival in vitro and lack of specificity towards breast cancer cells. However, 
further research could lead to the development of compound 1 analogues with 
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Legends for Figure 
 
Fig. 1. Structural formula of compound 1. 
 
Fig. 2 Compound 1 inhibits cell survival of SKBR-3, BT474 and MCF10A cells. Cells were 
cultured for 48 h in the presence of DMSO (Control culture, Ctr) or compound 1 at the 
indicated concentration. Cell survival was assessed by MTT assay. Cell survival in control 
culture was arbitrarily set to 100%. (A) Compound 1 shows inhibits cell survival of SKBR-
















of compound 1 are concentrations that inhibit at 50% the survival of SKBR-3 and BT474, 
respectively. Notice that compound 1 at the 50µM concentration strongly inhibits 
survival of MCF10A cells.  Mean values and standard deviation (indicated as vertical 
bars) (n=4) are shown. Asterisks indicate statistical significance P<0.001 (***). 
 
Fig. 3. Compound 1 induces cell cycle arrest of SKBR-3 and BT474 cells in the G0/G1 
phase. (A) High resolution DNA flow cytometric analysis of DAPI-stained nuclei of SKBR-
3 cells cultured for 48h with DMSO (Ctr) or 1 supplemented medium. Both floating and 
adherent cells were collected for the analysis. Mean values and standard deviation 
(indicated as vertical bars) (n=4) are shown. P<0.001 (***). 
(B) Representative DNA content histograms obtained by high-resolution DNA flow 
cytometry from SKBR-3 and BT474 cells treated with DMSO or (C) 1 supplemented 
medium. X axes show DNA content measured as intensity of fluorescent light emitted 
by DNA bound DAPI at 435 nm; Y axes show number of nuclei (counts). 
 
Fig. 4. Compound 1 induces apoptosis in SKBR-3 and BT474 cells. (A) Representative 
FCM plots of sytox blue and annexin V-APC fluorescence intensity, measured on 
channel FL6 and FL8, respectively, of SKBR-3 cells (left panels) and BT474 (right panels) 
after 48 h of exposure to compound 1 (1) or DMSO (Ctr). Both floating and adherent 
cells were collected for the analysis. Cells analyzed for sytox blue and annexin-APC 
fluorescence were gated in FCM plots of FSC vs SSC to exclude debris from the analysis 
(not shown). Percentage of cells included in each quadrant are shown. Early apoptotic 
cells (sytox blue negative and annexin V-APC positive) are included in the quadrant Q3. 
















DMSO (Ctr) is shown. Mean values and SD (indicated as vertical bars) (n=3) are shown. 
P<0.05 (*). (C) Immunoblot analysis of control (Ctr) or compound 1-treated (1) SKBR-3 
and BT474 cell lysates with an antibody against the Poly(ADP-Ribose) Polymerase 
(PARP). Tubulin was used as a loading control. Molecular masses of the protein bands 
are indicated in kDa on the right side. 
 
Fig. 5. Compound 1 reduces ERBB2 protein levels and induces ERK1/2 activation in 
SKBR-3 and BT474 cell lines. (A) Immunoblot analysis of SKBR-3 and BT474 cell lysates 
after 48 h of exposure to compound 1 (1) or DMSO (Ctr) with antibodies specific for 
ERBB2 N-terminal domain, ERK1/2 and phosphorylated ERK1/2 isoforms. Tubulin was 
used as a loading control. Notice that the vertical line indicates that samples were 
loaded on different gels. (B) ERK phosphorylation was further analyzed using a SureFire 
ERK assay. Mean pERK1/2 vs total ERK ratio and standard deviation (indicated as 
vertical bars) (n=3) are shown. P<0.001 (***). 
 
Fig. 6. Compound 1 induces ROS generation in SKBR-3 cells and survival of SKBR-3 and 
BT474 cells is enhanced by NAC. (A). Representative FCM plot of FL1 intensity vs. counts 
of SKBR-3 cells stained with H2DCFDA to measure ROS generation after 48 h of 
exposure to compound 1 (1) or DMSO (Ctr). Cells analyzed for H2DCFDA fluorescence 
were gated in FCM plots of FSC vs SSC to exclude debris from the analysis (not shown). 
(B) H2DCFDA mean fluorescence intensity (MFI) of cells stained after 48 h of exposure 
to compound 1 (1) or DMSO (Ctr). Mean values and standard deviation (indicated as 
vertical bars) (n=4) are shown. P<0.001 (***). (C, D) SKBR-3 and BT474 cells were 
















both 1 and NAC. Cell survival was assessed by MTT assay. Cell survival in control culture 
was arbitrarily set to 100%. Mean values and standard errors of the mean (indicated as 
vertical bars) (n=4) are shown. P<0.05 (#), P<0.01 (**,§§,##), P<0.001 (§§§,###). Statistical 
significance of 1 and 1+NAC vs. Ctr is indicated by §. Statistical significance of 1 and 
1+NAC vs. NAC is indicated by #. Statistical significance of 1+NAC versus 1 is indicated by 
*.  
 
Fig. 7. Compound 1 reduces mitochondrial protonic gradient in SKBR-3 and BT474 and 
impairs ATP production in SKBR-3 cells. (A, B) Mitochondrial protonic gradient was 
measured by FCM analysis using the FL2 mean fluorescence intensity (MFI) of SKBR-3 
and BT474 cells stained with JC1 after 48 h of exposure to compound 1 (1) or DMSO 
(Ctr). Mean values and SD (indicated as vertical bars) (n=3) are shown. P<0.001 (***). 
(C) ATP synthesis rate was measured by a luciferin/luciferase chemiluminescent method 
in SKBR-3 cells treated for 48h with DMSO (Ctr) or compound 1 (1). Mean values and SD 
(indicated as vertical bars) (n=3) are shown. P<0.001 (***). 
 
Fig. 8. Compound 1 causes mitochondrial network collapse and donuts formation.  
Mitochondria of SKBR-3 cells were stained by using MitoTracker Red CMXRos (red 
signal), whereas nuclei were stained with Hoechst 33342 (blue signal) after 48 h of 
exposure to compound 1 (A)  or DMSO (B). Arrows indicates mitochondrial network 
collapse, arrowheads indicate some donut-shaped mitochondria. Bar=64.5 µm. 
Compound 1 causes mitochondrial network remodeling of inner cristae membranes and 
discontinuity of the outer membrane in SKBR-3 cells. Ultrastructural analysis of 
















Representative TEM images showing mitochondria with alterations and remodeling of 
inner cristae membranes (D, E, arrows). Several mitochondria show a completely 
disorganized inner membrane topology (F, arrow) and discontinuity of the outer 
membrane (F, arrowhead). Scale bar: 500 nm. 
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